glp-1 max ShailyPen Axiom and ShailyPen Neo (GLP-1 pens) | Shaily GLP-1 Advanced Metabolic Extra Strength

Writingreview & editing: H.D., T.F., J.T., U.B., P.D

Published April 3, 2020

Challenges in studies of GLP-1 and in development of GLP-1R agonists In the era of rapid daily progress in biomedical science, it is surprising that it took almost 20 years from identification of GLP-1 to successful approval of the worlds first clinically utilized GLP-1R agonist

Earlier clinical studies show ELV001 is well tolerated and demonstrates early clinical activity

Because it might just be the beginning of a bigger shift, one where the same class of medicines that are reshaping our understanding of metabolism start to rewrite the playbook for addiction medicine too